Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Gynecologic 1Genitourinary 1

Conditions

Obesity 9Endometrial Neoplasms 5Prostatic Neoplasms 2Overweight 2Diabetes Mellitus 2Breast Neoplasms 2Weight Loss 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Opioid-Related Disorders 1Metabolic Syndrome 1Lymphoma, Follicular 1Insulin Resistance 1Inflammation 1Hyperplasia 1Endometrial Hyperplasia 1Dyslipidemias 1Colorectal Neoplasms 1

Interventions

Metformin 7Surveys and Questionnaires 3Nutrition Assessment 3Exercise 3Tirzepatide 2Therapeutics 2Tablets 2Standard of Care 2Specimen Handling 2Resistance Training 2Methods 2Interviews as Topic 2Glucose Tolerance Test 2Educational Status 2Biopsy 2tocilizumab 1tislelizumab 1pembrolizumab 1epalrestat 1donafenib 1amlodipine, atorvastatin drug combination 1Verapamil 1Urine Specimen Collection 1Testosterone 1Secretin 1Second Harmonic Generation Microscopy 1Risk Assessment 1Remote Consultation 1Preventive Health Services 1Practice Guidelines as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus × Tirzepatide × Clear all
NCT06751589 2026-04-13

A Study of a Weight Loss Intervention in People With Endometrial Cancer

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Recruiting
36 enrolled
GynecologicOther

Diabetes Mellitus, Obesity, Endometrial Neoplasms, Overweight

NCT06759701 2026-02-27

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
Genitourinary

Diabetes Mellitus, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡